Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

33 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Ex vivo susceptibility to antimalarial drugs and polymorphisms in drug resistance genes of African Plasmodium falciparum, 2016-2023: a genotype-phenotype association study.
Rosado J, Fola AA, Cojean S, Sarrasin V, Coppée R, Zaffaroulah R, Bouzayene A, Cicéron L, Houzé L, Crudale R, Musset L, Thellier M, Pradines B, Clain J, Bailey JA, Houzé S; Investigation Study Group. Rosado J, et al. Among authors: coppee r. medRxiv [Preprint]. 2024 Jul 19:2024.07.17.24310448. doi: 10.1101/2024.07.17.24310448. medRxiv. 2024. PMID: 39072017 Free PMC article. Preprint.
Ex vivo susceptibility to antimalarial drugs and polymorphisms in drug resistance genes of African Plasmodium falciparum, 2016-2023: a genotype-phenotype association study.
Rosado J, Fola AA, Cojean S, Sarrasin V, Coppée R, Zaffaroulah R, Bouzayene A, Cicéron L, Maréchal C, Thaboulet G, Moissant C, Wallus L, Houzé L, Imbert N, Crudale R, Musset L, Thellier M, Pradines B, Clain J, Bailey JA, Houzé S, Group IS. Rosado J, et al. Among authors: coppee r. Res Sq [Preprint]. 2024 Jul 19:rs.3.rs-4763649. doi: 10.21203/rs.3.rs-4763649/v1. Res Sq. 2024. PMID: 39070647 Free PMC article. Preprint.
Indigenous emergence and spread of kelch13 C469Y artemisinin-resistant Plasmodium falciparum in Uganda.
Awor P, Coppée R, Khim N, Rondepierre L, Roesch C, Khean C, Kul C, Eam R, Lorn T, Athieno P, Kimera J, Balikagala B, Odongo-Aginya EI, Anywar DA, Mita T, Clain J, Ringwald P, Signorell A, Lengeler C, Burri C, Ariey F, Hetzel MW, Witkowski B. Awor P, et al. Among authors: coppee r. Antimicrob Agents Chemother. 2024 Aug 7;68(8):e0165923. doi: 10.1128/aac.01659-23. Epub 2024 Jul 19. Antimicrob Agents Chemother. 2024. PMID: 39028193
Genomic epidemiology of SARS-CoV-2 in Senegal in 2020-2021.
Ba AA, Coppée R, Dieng A, Manneh J, Fall M, Gueye K, Sene PY, Ndiour S, Samaté D, Manga P, Diop Diongue O, Camara A, Padane A, Diallo S, Gueye SB, Camara M, Sesay AK, Toure-Kane C, Mboup S, Charpentier C, Diop-Ndiaye H. Ba AA, et al. Among authors: coppee r. J Infect Dev Ctries. 2024 Jun 30;18(6):851-861. doi: 10.3855/jidc.17796. J Infect Dev Ctries. 2024. PMID: 38990988 Free article.
Plasmodium ovale spp dhfr mutations associated with reduced susceptibility to pyrimethamine in sub-Saharan Africa: a retrospective genetic epidemiology and functional study.
Joste V, Coppée R, Bailly J, Rakotoarivony Y, Toko Tchokoteu FG, Achache S, Pradines B, Cottrell G, Ariey F, Khim N, Popovici J, Mita T, Groger M, Ramharter M, Egbo T, Juma DW, Akala H, Houzé S, Clain J; Investigation Study Group. Joste V, et al. Among authors: coppee r. Lancet Microbe. 2024 Jul;5(7):669-678. doi: 10.1016/S2666-5247(24)00054-5. Epub 2024 May 15. Lancet Microbe. 2024. PMID: 38761813 Free article.
Pharmaco-virological outcomes and genotypic resistance profiles among children and adolescents receiving a DTG-based regimen in Togo.
Konu YR, Takassi E, Peytavin G, Dapam N, Damond F, Oumarou WA, Zaidi M, Franco-Yusti AM, Dagnra CA, Le Hingrat Q, Coppée R, Descamps D, Diallo FBT, Ekouevi DK, Charpentier C. Konu YR, et al. Among authors: coppee r. Clin Infect Dis. 2024 May 15:ciae278. doi: 10.1093/cid/ciae278. Online ahead of print. Clin Infect Dis. 2024. PMID: 38748464
Higher Levels of SARS-CoV-2 Genetic Variation in Immunocompromised Patients: A Retrospective Case-Control Study.
Guilbaud R, Franco Yusti AM, Leducq V, Zafilaza K, Bridier-Nahmias A, Todesco E, Soulie C, Fauchois A, Le Hingrat Q, Kramer L, Goulenok T, Salpin M, Daugas E, Dorent R, Ottaviani S, Zalcman G, Ghosn J, Choquet S, Cacoub P, Amoura Z, Barroux B, Pourcher V, Spano JP, Louet M, Marcelin AG, Calvez V, Charpentier C, Descamps D, Marot S, Ferré VM, Coppée R. Guilbaud R, et al. Among authors: coppee r. J Infect Dis. 2024 Apr 12;229(4):1041-1049. doi: 10.1093/infdis/jiad499. J Infect Dis. 2024. PMID: 37956413
Proportion of APOBEC3-induced defective HIV DNA after 1 year of dolutegravir + lamivudine simplification in the ANRS 167 LAMIDOL trial.
Mazouz F, Bertine M, Coppée R, Storto A, Katlama C, Landman R, Cabié A, Peytavin G, Raffi F, Yazdanpanah Y, Descamps D, Joly V, Ghosn J, Charpentier C; LAMIDOL Study Group. Mazouz F, et al. Among authors: coppee r. J Antimicrob Chemother. 2023 Dec 1;78(12):2995-3002. doi: 10.1093/jac/dkad344. J Antimicrob Chemother. 2023. PMID: 37930812 Clinical Trial.
33 results